XML 22 R3.htm IDEA: XBRL DOCUMENT v3.25.4
CONSOLIDATED STATEMENTS OF OPERATION AND OTHER COMPREHENSIVE INCOME (LOSS) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Profit or loss [abstract]      
Revenues $ 364,780 $ 365,477 $ 331,993
Cost of Revenues (Exclusive of depreciation and amortization shown separately below) 54,979 61,020 62,270
Research and development expenses 58,059 49,992 49,684
Selling and marketing expenses 122,975 112,227 105,914
General and administrative expenses 33,194 41,237 51,051
Depreciation and amortization 63,124 58,676 78,285
Other expenses, net 0 1,504 1,765
Total operating costs 277,352 263,636 286,699
Operating Profit (loss) 32,449 40,821 (16,976)
Financing income (7,010) (6,657) (8,192)
Financing expenses 2,200 8,946 10,200
Financing expenses (income), net (4,810) 2,289 2,008
Profit (loss) before taxes on income 37,259 38,532 (18,984)
Tax expenses 12,216 3,095 2,503
Profit (loss) for the year 25,043 35,437 (21,487)
Other comprehensive income (loss) items:      
Foreign currency translation differences for foreign operations 2,824 (35) 2,126
Foreign currency translation for subsidiary sold reclassified to profit and loss 0 0 1,234
Total other comprehensive income (loss) for the year 2,824 (35) 3,360
Total comprehensive income (loss) for the year $ 27,867 $ 35,402 $ (18,127)
Earnings per share      
Basic earnings (loss) per share (in USD) $ 0.42 $ 0.51 $ (0.3)
Diluted earnings (loss) per share (in USD) $ 0.41 $ 0.51 $ (0.3)